Demonstration of CDX2 is Highly Antibody Dependant
Demonstration of CDX2 is Highly Antibody Dependant
复制标题
DOI:
10.1097/pai.0b013e318257f8aa
复制
发表时间:
2013-01-01
影响因子:
1.6
通讯作者:
Vyberg, Mogens
中科院分区:
文献类型:
--
作者:
Borrisholt, Martine;Nielsen, Soren;Vyberg, Mogens
Objects: CDX2 is a widely used immunohistochemical marker for intestinal differentiation in neoplasms. In the Nordic Immunohistochemical Quality Control external quality assessment scheme, only 45% of the laboratories participating in the CDX2 challenge in 2009 produced sufficient staining. A major cause of insufficient staining results appeared to be less successful primary antibody (Ab) clones. To evaluate the Ab performance in a standardized way, a comparative study was carried out.Materials and Methods: Tissue microarrays containing 309 nonneoplastic tissues and tumor samples with expected high, low, and no CDX2 expression were used. Five Abs were selected for comparison: EPR2764Y concentrated (Conc), EPR2764Y in a ready-to-use format, and DAK-CDX2, AMT28, and CDX2-88, all Conc. The CDX2 stains were scored blindly using the H-score method. Tissue/tumor samples with a maximum H-score of 150 to 300 (on the basis of the staining giving the highest score) were classified as CDX2 high expressors, samples with a maximum H-score of 10 to 149 as low expressors, and samples with a maximum H-score